Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial

• Gail J. Roboz,
• Hartmut Döhner,
• Christopher Pocock,
• Herve Dombret,
• Farhad Ravandi,
• Jun Ho Jang,
• Dominik Selleslag,
• Jiři Mayer,
• Uwe M. Martens,
• Jane Liesveld,
• Teresa Bernal,
• Ming Chung Wang,
• Peiwen Yu,
• Ling Shi,
• Shien Guo,
• Ignazia La Torre,
• Barry Skikne,
• Qian Dong,
• Julia Braverman,
• Salem Abi Nehme,
• C.L. Beach,
• Andrew H. Wei

Affiliations

Gail J. Roboz

Weill Cornell Medical College, New York, NY; New York Presbyterian Hospital, New York

Hartmut Döhner

Ulm University Hospital, Ulm

Christopher Pocock

Kent and Canterbury Hospital, Canterbury

Herve Dombret

Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP-HP) and Institut de Recherche Saint-Louis, Université de Paris, Paris

Farhad Ravandi

The University of Texas MD Anderson Cancer Center, Houston

Jun Ho Jang

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul

Dominik Selleslag

AZ Sint-Jan Brugge-Oostende AV, Bruges

Jiři Mayer

University Hospital Brno, Brno, Czech Republic

Uwe M. Martens

SLK-Kliniken GmbH, MOLIT Institute for Personalized Medicine, Heilbronn

Jane Liesveld

Wilmot Cancer Institute, University of Rochester, New York

Teresa Bernal

Hospital Universitario Central de Asturias, Oviedo

Ming Chung Wang

Chang Gung Medical Foundation, Kaohsiung

Peiwen Yu

Evidera, Waltham

Ling Shi

Evidera, Waltham

Shien Guo

Evidera, Waltham

Ignazia La Torre

Celgene, a Bristol-Myers Squibb Company, Boudry

Barry Skikne

Bristol Myers Squibb, Princeton, NJ; University of Kansas Medical Center, Kansas City

Qian Dong

Bristol Myers Squibb, Princeton

Julia Braverman

Bristol Myers Squibb, Princeton

Salem Abi Nehme

Celgene, a Bristol-Myers Squibb Company, Boudry

C.L. Beach

Bristol Myers Squibb, Princeton

Andrew H. Wei

The Alfred Hospital and Monash University, Melbourne